Clinical Trial Expertise Key To Early-Stage Company Deals – Medtronic COO
This article was originally published in The Gray Sheet
Executive Summary
Clinical data quality and integrity should be the main consideration for manufacturers evaluating a merger or alliance with an early-stage technology developer, according to Medtronic COO Bill Hawkins